- 专利标题： PHARMACEUTICAL FORMULATIONS FOR TREATING ENDOMETRIOSIS, UTERINE FIBROIDS, POLYCYSTIC OVARY SYNDROME OR ADENOMYOSIS
-
申请号： US18168221申请日： 2023-02-13
-
公开(公告)号： US20230255968A1公开(公告)日： 2023-08-17
- 发明人: Jayanthy Jayanth , Kevin C. Spence , Gregory A. McClelland , Anna V. Stepanenko , Kristof Chwalisz , Charlotte D. Owens , James W. Thomas , Jane Castelli-Haley , Keith Gordon , Michael C. Snabes , Ahmed M. Soliman , Geoff Zhang , David Metzger , Yanxia Li , Tzuchi R. Ju , Xi Shao , Oscar Antunez Flores , Rita Jain , Juki Wing-Keung Ng , Janine D. North , Hannah Palac , Paul M. Peloso
- 申请人： AbbVie Inc. , Neurocrine Biosciences, Inc.
- 申请人地址： US IL North Chicago
- 专利权人： AbbVie Inc.,Neurocrine Biosciences, Inc.
- 当前专利权人： AbbVie Inc.,Neurocrine Biosciences, Inc.
- 当前专利权人地址： US IL North Chicago
- 优先权： WO TUS2018043321 2018.07.23
- 主分类号： A61K31/513
- IPC分类号： A61K31/513 ; A61K9/20 ; A61P5/30 ; A61P15/00
摘要：
The present disclosure relates to pharmaceutical compositions comprising a gonadotropin-releasing hormone (GnRH) antagonist and methods of preparing and using such compositions. The disclosure also relates to methods of facilitating release of a GnRH antagonist from a pharmaceutical composition.
公开/授权文献
信息查询
IPC分类:
